An integrated, self-contained microfluidic cassette for isolation, amplification, and detection of nucleic acids by Chen, Dafeng et al.
University of Pennsylvania
ScholarlyCommons
Departmental Papers (MEAM) Department of Mechanical Engineering & AppliedMechanics
4-2010
An integrated, self-contained microfluidic cassette
for isolation, amplification, and detection of nucleic
acids
Dafeng Chen
University of Pennsylvania, dafeng@seas.upenn.edu
Michale Mauk
University of Pennsylvania
Xianbo Qiu
University of Pennsylvania
Changchun Liu
University of Pennsylvania
Jitae Kim
University of Pennsylvania
See next page for additional authors
Follow this and additional works at: http://repository.upenn.edu/meam_papers
Part of the Biomechanical Engineering Commons, Biomedical Engineering and Bioengineering
Commons, and the Biotechnology Commons
Postprint version.
Suggested Citation:
Chen, D. et al. An integrated, self-contained microfluidic cassette for isolation, amplification, and detection of nucleic acids. Biomedical Microdevices.
Vol. 14(4). p. 705-19.
http://dx.doi.org/10.1007/s10544-010-9423-4
The final publication is available at http://www.springerlink.com
Recommended Citation
Chen, Dafeng; Mauk, Michale; Qiu, Xianbo; Liu, Changchun; Kim, Jitae; Ramprasad, Sudhir; Ongagna, Serge; Abrams, William;
Malamud, Daniel; Corstjens, Paul; and Bau, Haim H., "An integrated, self-contained microfluidic cassette for isolation, amplification,
and detection of nucleic acids" (2010). Departmental Papers (MEAM). 271.
http://repository.upenn.edu/meam_papers/271
An integrated, self-contained microfluidic cassette for isolation,
amplification, and detection of nucleic acids
Abstract
A self-contained, integrated, disposable, sample-to-answer, polycarbonate microfluidic cassette for nucleic
acid-based detection of pathogens at the point of care was designed, constructed, and tested. The cassette
comprises on-chip sample lysis, nucleic acid isolation, enzymatic amplification (polymerase chain reaction
and, when needed, reverse transcription), amplicon labeling, and detection. On-chip pouches and valves
facilitate fluid flow control. All the liquids and dry reagents needed for the various reactions are pre-stored in
the cassette. The liquid reagents are stored in flexible pouches formed on the chip surface. Dry (RT-)PCR
reagents are pre-stored in the thermal cycling, reaction chamber. The process operations include sample
introduction; lysis of cells and viruses; solid-phase extraction, concentration, and purification of nucleic acids
from the lysate; elution of the nucleic acids into a thermal cycling chamber and mixing with pre-stored (RT-
)PCR dry reagents; thermal cycling; and detection. The PCR amplicons are labeled with digoxigenin and
biotin and transmitted onto a lateral flow strip, where the target analytes bind to a test line consisting of
immobilized avidin-D. The immobilized nucleic acids are labeled with up-converting phosphor (UCP)
reporter particles. The operation of the cassette is automatically controlled by an analyzer that provides pouch
and valve actuation with electrical motors and heating for the thermal cycling. The functionality of the device
is demonstrated by detecting the presence of bacterial B.Cereus, viral armored RNA HIV, and HIV I virus in
saliva samples. The cassette and actuator described here can be used to detect other diseases as well as the
presence of bacterial and viral pathogens in the water supply and other fluids.
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Abstract 
A self-contained, integrated, disposable, sample-to-answer, polycarbonate microfluidic cassette for 
nucleic acid – based detection of pathogens at the point of care was designed, constructed, and tested. The 
cassette comprises on-chip sample lysis, nucleic acid isolation, enzymatic amplification (polymerase chain 
reaction and, when needed, reverse transcription), amplicon labeling, and detection. On-chip pouches and 
valves facilitate fluid flow control. All the liquids and dry reagents needed for the various reactions are 
pre-stored in the cassette. The liquid reagents are stored in flexible pouches formed on the chip surface. Dry 
(RT-)PCR reagents are pre-stored in the thermal cycling, reaction chamber. The process operations include 
sample introduction; lysis of cells and viruses; solid-phase extraction, concentration, and purification of 
nucleic acids from the lysate; elution of the nucleic acids into a thermal cycling chamber and mixing with 
pre-stored (RT-)PCR dry reagents; thermal cycling; and detection. The PCR amplicons are labeled with 
digoxigenin and biotin and transmitted onto a lateral flow strip, where the target analytes bind to a test line 
consisting of immobilized avidin-D. The immobilized nucleic acids are labeled with up-converting phosphor 
(UCP) reporter particles. The operation of the cassette is automatically controlled by an analyzer that 
provides pouch and valve actuation with electrical motors and heating for the thermal cycling. The 
functionality of the device is demonstrated by detecting the presence of bacterial B.Cereus, viral armored 
RNA HIV, and HIV I virus in saliva samples. The cassette and actuator described here can be used to detect 
other diseases as well as the presence of bacterial and viral pathogens in the water supply and other fluids. 
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1.  Introduction 
In recent years, there has been a growing interest in developing integrated, self-contained, portable, 
disposable, inexpensive microfluidic devices for point-of-care diagnostics [1-4]. These devices require 
integration, automation, and miniaturization of liquid handling, sample processing, and analysis to facilitate 
fast diagnostics, low cost, operation by minimally trained personnel, and low contamination risk.  
Nucleic acid-based assays are commonly used in medical laboratories because of their high specificity 
and sensitivity [5]. Since its advent in the mid 1980s, polymerase chain reaction (PCR) has been one of the 
most important tools for molecular diagnosis, enabling the amplification of target templates containing just a 
few molecules to detectable levels. For the amplification of RNA targets, reverse transcription-PCR (RT-PCR) 
is needed, in which RNA strands are first reverse transcribed into their DNA complement, followed by 
amplification of the resulting DNA using standard PCR. For efficient and selective amplification, PCR 
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requires rapid temperature transitions as well as precise temperature control. Conventional bench-top PCR 
thermal cyclers can have slow heating/cooling rates due to their large thermal mass and as a result rapid 
thermal cycling has been one of the early motivations for the development of low thermal inertia, PCR chips. 
Various micro PCR devices, ranging in volume from nano-liters to microliters, have been fabricated in 
silicon [6-8], glass [9-11], ceramics [12, 13], and polymeric materials such as PDMS [14, 15], PMMA [16], 
polyimide [17], and polycarbonate [18-21]. 
Since PCR and RT-PCR processes are sensitive to the presence of inhibitors in the sample, appropriate 
sample preparation is essential for successful nucleic acid amplification. Typically, sample preparation steps 
include sample metering, cell/virus lysis, and nucleic acid isolation and concentration. To facilitate 
PCR-based tests at the point of care, it is ideal to integrate sample preparation steps with the enzymatic 
reactions into a single platform. Due to the complexity of the sample preparation, however, most of the 
reported microfluidic PCR devices focus predominantly on the amplification and detection/analysis steps [11, 
14, 22-25], while the sample preparation and nucleic acid extraction are deferred to bench-top equipments. 
For example, Woolley et al. [25] presented a silicon-based PCR reactor integrated with a glass-based 
capillary electrophoresis (CE) chip for the detection of a β-globin target within 20 min. Huang et al. [23] 
described a microfluidic chip capable of performing DNA/RNA amplification, electrokinetic injection and 
separation of (RT-)PCR products, and on-line optical detection of the nucleic acid products. Koh et al. [26] 
presented an integrated, plastic microfluidic device for PCR and electrophoretic separation to detect bacteria. 
In their design, the PCR products were transported electrokinetically through a gel valve and then separated 
electrophoretically. As one alternative to electrophoretic separation, fluorescence-based, real-time DNA 
detection offers fast, quantitative detection and simplifies chip design [27-30]. 
Although other researchers have developed microfluidic devices for cell lysis and nucleic acid extraction 
[31, 32], there are just a few reports of nearly fully integrated PCR-based biochips that perform all the 
necessary steps from sample introduction to target detection. Rosa et al. [33] demonstrated an integrated 
microfluidic system that employed dielectrophoresis to pre-concentrate B. pertussis cells, lysed the cells with 
electroporation, and carried out amplification and detection. Anderson et al. [21] reported on an integrated 
device that purified RNA from a serum lysate and carried out PCR, serial enzymatic reactions, and nucleic 
acid hybridization. Easley et al. [34] described an integrated microfluidic device that performed nucleic acid 
purification, amplification, and microchip electrophoretic detection. The sample and reagents were, however, 
delivered with an external syringe pump. Liu et al. [4] presented an integrated biochip that carried out 
sample preparation, PCR, and microarray-based detection of DNA. More recently, Beyor et al [35] reported 
an integrated lab-on-a-chip system for pathogen detection comprised of cell preconcentration, purification, 
polymerase chain reaction (PCR), and capillary electrophoretic (CE) analysis. In all the above cases, some of 
the operations were either carried out outside the chip or the operator had to interact with the process stream 
by introducing reagents at the appropriate times. A few PCR-based integrated systems have also been 
developed by companies. For instance, Rheonix, Inc. (Ithaca, NY) demonstrates an integrated cassette 
(CARD) capable of pumping reagents and processing samples. At its current state of development, the 
Rheonix system’s user must pipette reagents into wells in the CARD at the beginning of the process. Cepheid 
(Sunnyvale, CA) developed an integrated real-time PCR system GeneXpert capable of sample preparation and 
DNA amplification and detection. The GeneXpert is a laboratory-based system. 
Although dry reagents have long been used in lateral flow immunoassays [36], they are rarely used in 
nucleic acid-based, point-of-care assays. While Weigl et al. [37] presented a procedure for preparing and 
handling dry reagent storage for microfluidic assays, the reagents were not pre-stored in the chip. Brivio et al. 
[38] demonstrated on-chip PCR amplification with freeze-dried [39] reagents stored in the polymer PCR 
chips. In their work, long-term stability of the reagents was emphasized, but there was little discussion of the 
flow control and the integration of reagent storage into the chip. 
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In this paper, we report on a self-contained, integrated, disposable, sample-to-answer, polycarbonate 
microfluidic cassette that performs sample lysis, nucleic acid isolation, enzymatic amplification, amplicon 
labeling, and detection for point-of-care identification of pathogens. The cassette includes on-board storage 
of all required liquid buffers and dry reagents, as well as on-chip pumping of liquid solutions and on-chip 
valves for fluid control. The analysis starts with sample introduction, followed by mixing the sample with 
lysis/binding buffer and solid-phase extraction (SPE) of nucleic acids from the lysate. The eluted template is 
then delivered into a PCR chamber that contains pre-stored dry reagents. The thermal cycling for enzymatic 
amplification is facilitated with two thermal electric (TE) modules that sandwich the PCR chamber. The 
amplicon is detected on-chip with a lateral flow strip [1]. The device was tested with pathogenic bacterial B. 
cereus, viral Armored RNA, and HIV samples. The gram-positive B cereus bacterium served as a model 
organism for DNA-based detection. The Armored RNA HIV particles consists of RNA molecules 
encapsulated in a MS2 bacteriophage shell [40] and served as a model for viral RNA detection and as a safe 
surrogate for the HIV virus. 
 
2. Methods and materials 
The test system consists of an integrated, disposable, single use cassette and an electronically controlled 
analyzer. The cassette houses the various reagents and all the functional components such as pouches, valves, 
reaction chambers, membranes, and conduit networks needed for the process operations. The analyzer 
provides mechanical actuation for the on-chip pouches and valves for liquid pumping and flow control in the 
cassette. The analyzer also includes a pair of thermoelectric units to provide thermal cycling for (RT-)PCR. 
After loading the sample, the cassette is self-contained, and designed to avoid exchange of liquids between 
the cassette and actuator, reducing risk of contamination. Subsequent to the introduction of a biological 
sample (e.g., saliva, serum, urine, cell culture), the cassette is inserted into the analyzer and all the necessary 
operations are carried out automatically.  
 
2.1 Cassette design, fabrication, and operation 
Cassette Design. The cassette has two states: a “storage state” in which all the reagent compartments 
are sealed for long-term storage and an “activated state” in which the reagent compartments are connected to 
channels and reaction chambers [3]. To activate the cassette, the sealing foil is removed and replaced with a 
flexible, attached cover film that contains connecting conduits. The cover film is permanently affixed to the 
cassette to assure proper alignment of the connecting conduits with the vias in the cassette.  
The cassette is schematically depicted in Fig. 1. Fig.1A and 1B are, respectively, a top view of the 
cassette and cross-sections along the length of the cassette prior (B1) and after (B2) the cassette’s activation. 
The cassette consists of a variety of functional components, including reagents’ storage pouches (P1 – P6), 
on-chip diaphragm valves (V1-V4), a sample mixing chamber, a nucleic acid isolation chamber equipped 
with a silica membrane, a (RT-)PCR chamber preloaded with dried reagents, and a lateral flow strip for 
detection of (RT-)PCR products. Note that the heaters H1 and H2 shown in Fig. 1 are components of the 
analyzer but not of the cassette. Fig. 2 is a photograph of the assembled cassette in its storage state. For 
better visibility, the pouches for the storage of the liquid reagents are filled with dyes. The liquid reagents 
include binding/lysing buffer, inhibitor removal buffer, wash buffer, elution buffer, lateral flow buffer, and 
UCP reporter buffer. 
Fabrication. The cassette consists of a 71 mm long × 48 mm wide, 5.84 mm thick polycarbonate (PC) 
body, which was machined and patterned with a computer numerical control (CNC) milling system (HAAS 
Automation Inc., Oxnard, CA). The chip is designed to be compatible for quantity production by injection 
molding. Hemispherical wells for the pouches and valve seats were milled on the top surface and equipped 
with two access ports at the well bottom (Figure 4a). To form the pouches, the pouch wells, differing in size 
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according to the volume of liquid needed for the particular process, are capped with a 120 µm thick 
polycarbonate film using solvent (acetonitrile) bonding. A custom-made punch that matches the well’s 
topology deformed the polycarbonate film to form an inverted hemisphere. Compressed air was then 
delivered into the well through the ports causing the hemisphere to snap into upright position (see Qiu et al. 
[41] for additional details on the pouch manufacturing,). The pouch was then completely filled through one 
of the access ports with the appropriate buffer and the ports were sealed. For long-term storage, an additional, 
removable, barrier film, such as aluminum foil can cover the pouches, to minimize permeation of moisture 
through the polycarbonate film.  
To form the diaphragm valves, a 45 µm thick polyolefin film (Syfan Corp., Everetts, NC, USA) was 
bonded over the valve seat with a pressure-sensitive adhesive tape (3M Co., Minnesota, USA). The gap 
between the valve seat and the membrane was dictated by the thickness of the adhesive tape and was 
approximately 250 µm. A waste chamber, lateral flow strip chamber, and mixing chamber were also 
machined on the cassette’s top surface (Fig. 1).  
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Fig. 1: A schematic of the polycarbonate fluidic chip consisting of reagents storage pouches (P1 – P6), 
on-chip diaphragm valves (V1-V4), a mixing chamber, a nucleic acid isolation chamber housing a silica 
membrane, a (RT-)PCR chamber preloaded with dried reagents, an amplicon dilution trap, a waste chamber 
and liquid trap, and a lateral flow strip. (A) Top view; (B) cross-sections along the length of the cassette 
(indicated with the arrows B-B in A) showing the cassette in storage state (B1) and operating (after activation) 
state (B2). Note that heaters H1 and H2 are components of the analyzer but not of the cassette. ‘TE’ denotes 
the thermoelectric modules. 
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A nucleic acid isolation chamber containing a silica membrane was formed on the bottom surface. 
The silica membrane (glass fibers) was cut into a 2mm diameter disk with a CO2 laser (Universal Laser 
Systems, Scottsdale, Arizona, USA). The silica membrane was supported by a perforated disk made of 
polycarbonate. Molten paraffin was dispensed around the membrane’s seat perimeter prior to the silica disk’s 
insertion. Subsequent to the silica disk insertion, the paraffin was heated and softened. The silica disk was 
pushed against the paraffin to ensure sealing between the membrane and the chamber walls.  
A 20 µl, 400µm tall (RT-)PCR chamber was fabricated in the bottom layer. The chamber was capped 
with a 120µm thick polycarbonate film. Additionally, the cassette was thinned at the location of the PCR 
reactor. A thin walled, shallow reactor was used to reduce thermal resistance and to improve temperature 
uniformity. The different compartments were connected with a network of milled conduits (Figs. 1 and 2) of 
square cross-sections with widths and depths ranging from 250 µm to 500 µm. 
All the liquid and dried reagents were loaded into the cassette at the conclusion of its manufacturing. 
The various buffers were stored in the pouches. Pouch P1 stores the binding/lysis buffer; pouch P2 stores the 
inhibitor-removal buffer; pouch P3 stores the wash buffer; pouch P4 stores the elution buffer; pouch P5 
stores the lateral flow buffer; and pouch P6 stores the labels’ suspension. Dried (RT-)PCR reagents were 
loaded into the PCR reaction chamber and passivated with a paraffin film (AmpliWax, Applied Biosystems 
Inc, Foster City, CA) before the PCR chamber was capped. The paraffin film serves to protect the dried 
reagents from the surrounding air during storage and from any liquids that are transmitted through the 
chamber [20, 42] until melted at 58˚C prior to amplification.  
Operation. Prior to sample introduction, the sealing layer is removed and replaced with the attached 
connecting cover film (Fig. 1-B2). The connecting cover film is made of polymer film in which conduits 
have been machined with the CO2 laser. The flexible connecting cover is permanently attached to the PC 
cassette to assure appropriate alignment of the connecting conduits with the various openings in the main 
body of the cassette. Once the cover film is affixed to the cassette’s main body, the conduits in the film form 
connections between the various pouches’ outlets and the downstream fluidic networks.  
An analyzer (Fig. 3) is used to actuate the cassette and to effectuate various process operations in the 
desired, pre-programmed sequence. Mechanical actuation is accomplished with miniature, linear motors that 
controllably lower plungers either to compress pouches or to compress membranes for valve closure or fluid 
delivery. The analyzer also houses thermoelectric heaters to provide thermal cycling for the PCR reaction, a 
heater to remove any residual ETOH from the silica membrane, a vibrator to enhance mixing, and a vacuum 
pump. The analyzer is described in greater detail later on. 
Subsequent to the sample introduction into the mixing chamber and engagement of the connecting film, 
the cassette is inserted into the analyzer and makes a quick connection with a vacuum line. Once the analyzer 
is instructed to start, plungers lower in a predetermined, timed sequence to compress the pouches and 
discharge the reagents. We describe below the sequence of processes used to analyze RNA viruses.  
Initially, valve V1 (Fig. 1) is closed. Compression of pouch P1 leads to the discharge of the binding 
buffer containing chaotropic salts into the mixing chamber, where it mixes with the sample. Once 
compressed, the plunger remains in the down position, preventing the pouch from rebounding and causing 
backflow. The force exerted on the cassette by the plunger ensures that the cassette is in good thermal contact 
with the heating elements. An electrically controlled, miniature, vibrating disk motor (Solarbotics Ltd., 
Calgary, Canada) attached to the bottom of the mixing chamber shakes the chamber for 1 min to enhance 
mixing during the lysis step. After the incubation step, valve V1 opens and valve V3 closes. The lysate is 
then forced to flow through the silica membrane (Roche Applied Science, Mannheim, Germany) with the aid 
of a micro vacuum pump (Hargraves Technology Corp., Mooresville, NC 28117 USA). In the presence of 
chaotropic salts (e.g., guanidine-HCl) [43], nucleic acids bind to the silica membrane, while the other lysate 
constituents flow through the membrane to the cassette’s waste chamber. The waste chamber contains a 
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liquid trap to prevent any liquids from leaving the cassette through the vacuum line. Subsequently, pouches 
P2 and P3 are compressed in sequence to transmit, respectively, inhibitor removal buffer and wash buffer 
through the membrane. The solutions wash away from the membrane any unwanted mineral salts, enzyme, 
proteins and other small molecules.  
Next, heater H1 (Fig. 1B2) is turned on, and the membrane is dried with heated air driven by the 
vacuum pump to remove residual volatile contaminants that may inhibit the subsequent amplification 
reaction. Valve V2 is then closed, valve V3 opens, and pouch P4 discharges elution buffer (low molarity Tris 
buffer solution or nuclease-free water) through the membrane to desorb bound RNA. The eluted RNA is 
transferred into the RT-PCR chamber and fills-up the chamber. The upstream (V3) and downstream (V4) 
valves surrounding the PCR chamber are closed to seal the chamber. Heater H2 (Fig. 1B2) is activated to 
heat the chamber to ~58˚C for 1 min to melt the paraffin seal and release the reagents.  
Once the reagents are released, the PCR chamber temperature is lowered to 50˚C for 30 min for the 
reverse transcription (RT) reaction. Subsequent to the RT step, the thermal cycling is performed. Once the 
thermal cycling has been completed, valves V3 and V4, open and on-chip detection of the PCR products is 
carried out with the lateral flow assay (see section 2.7). Material from the PCR chamber is mixed with lateral 
flow buffer by compressing pouch P5 and transferred to the lateral flow strip sample pad. A liquid trap, 
consisting of a well located downstream of the PCR chamber, captures 90% of the PCR product’s volume 
and allows only 10% of the products to proceed to the loading pad of the lateral flow strip. The 
amplicon-buffer blend migrates up the strip by capillary forces. The strip includes test zones with 
immobilized ligands that specifically bind to the target analytes in the sample and a control zone that binds 
the labels that were not captured in the test zone. The control line is provided to assure the integrity of the 
process. After a predetermined time interval (2 min), pouch P6 is compressed to discharge buffer containing 
functionalized UCP reporter particles onto the lateral flow strip’s sample pad. The particles migrate up the 
strip and bind to the immobilized target molecules at the test line and the capture molecules at the control 
line. Although in the studies reported here up-converting phosphor (UCP) particles were employed as the 
reporters, the cassette can utilize any other functionalized labels such as gold particles (which facilitate 
visual detection), quantum dots, or fluorophores. Finally, a fluorescence reader scans the strip and outputs 
RFU readings for analysis. The test results are reported in terms of the ratio of the signal intensity detected at 
the test and control lines. The sequence of operation described above for on-chip nucleic acid testing is 
summarized in the ESI (Electronic Supporting Information) Table S1. 
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Fig. 2: A photograph of the assembled, nucleic acid cassette in its storage state. For better visibility, the 
various storage pouches were filled with dyes. Pouch P1 (100 μl) contains the binding/lysis buffer; pouch P2 
(60 μl) contains the inhibitor removal buffer; pouch P3 (100 μl) stores the wash buffer; pouch P4 (40 μl) 
contains the elution buffer; pouch P5 (60 μl) contains the lateral flow buffer; and pouch P6 (60 μl) contains a 
suspension of UCP reporter particles. 
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2.2 The Analyzer 
The portable analyzer controls all the tasks performed in the cassette, including fluid pumping and 
valving, thermal cycling, and signal scanning, reading, and analysis, but the analyzer is not disposable. It is 
designed to enable rapid insertion and discharge of cassettes. The analyzer (Fig. 3) comprises miniature 
linear actuators to compress pouches and close valves, a pair of thermoelectric (TE) units and a heat sink for 
thermal control of the enzymatic reaction chamber, a K-type thermocouple for temperature sensing, a 
micro-vacuum pump, a liquid trap, and a microcontroller. A fluorescence reader will be integrated into the 
device in the future for scanning the lateral flow strip. Alternatively, the amplification process can be 
monitored in real time. The microcontroller schedules and directs the operations of the various components. 
Currently, the control and data processing software reside on an external computer to allow easy 
modifications in the sequence and timing of operations through a friendly GUI (Graphical User Interface). In 
the future, the software will be downloaded onto the microcontroller and a touch screen display could be 
used for interactions between the user and the device.  
Linear Actuator
Reader
TE
Heat Sink
PC
Controller
Thermocouple
(K type)
Power
Supply
THE ANALYZER
Micro
Vacuum
Trap/
Filter
Chip/PCR Chamber
TE
 
Fig. 3: A schematic depiction of the analyzer comprising linear actuators, a pair of thermoelectric (TE) 
units and a heat sink, a K-type thermocouple, a micro-vacuum pump, a liquid trap, and a microcontroller. All 
the components are packaged in a portable box. The external computer (PC) provides user interface and data 
analysis software. 
 
2.3 Pumping and Valving  
The storage of liquids and the pumping functions are carried out by a system of pouches. Each pouch 
(Fig. 4a) consists of a cavity milled in the plastic substrate with a rounded end mill and covered with a thin 
shell dome. When the cassette is inserted into the analyzer, it is aligned so that each pouch resides beneath a 
linear actuator equipped with a ball-shaped plunger. When the plunger descends, it deforms the membrane to 
discharge the liquid out of the pouch through the exit port. Pouches of volumes ranging from 8 μl to 210 μl 
have been fabricated to accommodate various assays’ needs. The amount of liquid to be discharged is 
dictated by the pouch’s volume. Although it is possible to program the linear actuator for multiple discharges 
from the same pouch, in most of our applications, we discharged (slowly) the entire pouch’s volume in a 
single stroke. Once the discharge operation has been completed, the plunger stays in its down position until 
the conclusion of all chip operations. 
To accommodate valving, we designed and constructed simple, normally open, on/off, diaphragm 
valves (Fig. 4b). The valves are actuated by the same linear motors used to actuate the pouches. As the 
plunger descends, it deforms the flexible diaphragm and closes the valve. Although the valves need to last 
just a few (<3) cycles, they proved to be quite durable, and provide a sufficient seal to prevent the escape of 
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liquid from the (RT-)PCR chamber during thermal cycling.  
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Fig. 4: Schematic of the on-chip pumping and valving. (a) Fluid stored in the pouch is “excreted” out 
through the pouch’s exit port when the plunger deforms the pouch membrane. The pouch’s volume 
determines the discharged fluid’s volume, and the actuation speed determines the dispensing rate. (b) 
Actuation of the on-chip, normally open diaphragm valve. The vertical movement (in Z direction) of the 
piston is generated with a linear actuator. 
 
2.4 Mixing Chamber 
Rapid mixing of fluids and particles is essential in many fluidic devices. Since, in most cases, diffusion 
is too slow, one must rely on fluid motion to stir the fluid [3, 44]. Here, we use a miniature, planar, vibrating 
disk motor (VDM) (Solarbotics Ltd., Calgary, Canada) to facilitate stirring in the 150 µl mixing chamber. A 
12mm diameter×3.4mm thick planar vibrating disk contacts the bottom surface of the mixing chamber (Fig. 
5a). When energized, the vibrating disk generates high-frequency vibrations, which, in turn, induce 
circulation in the mixing chamber.   
To demonstrate the stirrer’s performance, we filled the mixing chamber with green and red dyes (Fig. 
5b1). In the absence of stirring, very little mixing occurred by diffusion alone. After 15 s, the interface 
between the green and red dyes is clearly visible (Fig. 5b2). In contrast, when the stirrer was active, within 
15 s, the two fluids blended to form a homogeneous solution (Fig. 5b3).  
Support
Mixing
Chamber
Vibrating
Disk
Polycarbonate Body
Fluid 1
Fluid 2
(a)    
Fig. 5: (a) A schematic of the on-chip mixing chamber. The mixing process is enhanced with a low-power, 
high frequency, miniature, vibrating disk motor (VDM) placed next to the bottom surface of the mixing 
chamber (purple). The VDM is housed in the analyzer. (b) Image b1 features two distinguishable fluids (red 
and green) at the time of their introduction into the mixing chamber; b2 shows the two fluids after 15 s of 
diffusion; b3 shows the mixture of the two fluids after 15-seconds of stirring with the VDM. (The dashed 
line in Figs. b1 and b2 delineates the interface between the two dyes for the benefit of readers who do not 
have access to color images). 
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2.5 Solid Phase Extraction of Nucleic Acids 
Our device is designed for the extraction, amplification, and detection of DNA or RNA targets. The 
commonly used silica-based solid phase extraction  [1, 32, 43, 45, 46] technique is applicable for both. 
Solid-phase extraction provides an effective means for the isolation and purification of nucleic acids from 
cell lysates. The lysate is first mixed with a chaotropic agent such as guanidinium HCl. The mixture is then 
forced through a porous silica matrix such as a porous, glass fiber membrane. The chaotropic agent induces 
selective binding of the nucleic acids to the silica phase. The bound nucleic acid is washed with 
ethanol-based buffers and subsequently eluted with a low-salt, neutral-pH buffer that is compatible with 
(RT-)PCR. The chaotrope-silica method of nucleic acid isolation is widely used on a benchtop with a 
spin-column. For the extraction of bacterial DNA, we modified the QIAGEN DNeasy Tissue Kit (QIAGEN 
Inc., Valencia, CA 91335) protocol. For the extraction of viral RNA, we modified the Roche High Pure Viral 
RNA Kit (Roche Applied Science, Indianapolis, IN 46250) protocol by replacing the centrifugation steps 
with vacuum driven suction through the silica membrane. The silica membrane was reduced in size to a 2mm 
diameter disk and the volume of the various reagents was adjusted accordingly. 
 
2.6 PCR Reagents 
Dried PCR reagents were prepared and pre-stored in the PCR chamber [20, 42]. When the reagents 
were reconstituted during PCR, the concentration of the various components were: 10 mM Tris-HCl (pH 9.0), 
50 mM KCl, 1.5 mM MgCl2, 200 μM dNTP, and 0.4 μg/μl BSA. The concentration of Taq DNA polymerase 
(GE Healthcare, Buckinghamshire, UK) was 0.1 unit/μl. For RT-PCR, the concentration of reverse 
transcriptase (Promega Corp., Madison, WI) was 0.1 unit/μl. 
When experimenting with B. cereus bacterium, the B. cereus genomic DNA (5,244,283 bp) was used 
as the PCR template. The forward and reverse primers (0.3 µM each) were, respectively, 5′-biotin-TCT CGC 
TTC ACT ATT CCC AAG T-3′ and 5′-digoxigenin-AAG GTT CAA AAG ATG GTA TTC AGG-3′ [1]. The 
primers targeted a specific 305 bp gene sequence. The PCR amplification resulted in the production of 
double-stranded DNA amplicons with 5′-Dig hapten on one strand and 5′-Bio hapten on the opposite strand. 
The on-chip PCR protocol was initiated with a denaturation step at 94˚C for 120 s, followed by 25 
amplification cycles (94˚C, 15 s; 55˚C, 23 s, 72˚C, 20 s), and terminated with an extension step at 72˚C for 
another 120 s. The total (unoptimized) time for the on-chip PCR was 28 min. 
When we experimented with Armored RNA HIV (Asuragen, Inc., Austin, TX 78744) [40], the 
forward and reverse primers (0.6 µM each) were, respectively, 5'-biotin- TAC TAG TAG TTC CTG CTA 
TGT CAC TTC C-3' and 5'-digoxigenin-AGT GGG GGG ACA TCA AGC AGC CAT GCA AAT-3'. The 
primers targeted a 155 bp gag fragment of the HIV genome [47]. The on-chip RT-PCR protocol was initiated 
with incubation at 45˚C for 30 min and a denaturation step at 95˚C for 120 s, followed by 25-35 
amplification cycles (95˚C, 45 s; 58˚C, 45 s, 72˚C, 60 s), and terminated with an extension step at 72˚C for 
another 10 min. The RT-PCR product was 155 base pairs. 
In parallel with the on-cassette experiments, control tests with 25 µL total volume were carried out 
with a standard benchtop PCR thermocycler (TC-312, Techne Incorporated, Princeton NJ). The benchtop 
PCR protocol used the same conditions as the cassette protocol, but had a relevantly slower cooling/heating 
rate inherent in the benchtop PCR system. PCR products were separated by agarose gel (2%) electrophoresis 
and stained with ethidium bromide (0.3 µg/ml). 
 
2.7 Detection of Amplicons 
To detect the presence of target amplicons, we used a UCP-lateral flow assay (UCP-LF) [48]. The 
UCP-LF assay provides a rapid and sensitive detection of the analytes [1, 3, 48], with the capability for 
multiplex detection of DNA and antigens/antibodies on a single strip. The lateral flow (LF) buffer consisted 
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of 100 mM Hepes (pH 7.2), 270 mM NaCl, 0.5% (v/v) Tween-20, and 1% (w/v) BSA (Sigma #A7030). The 
immunolabeling buffer was a mixture of LF buffer with mouse anti-Dig conjugated UCP reporter particles to 
label the haptenized DNA. The LF strips (OraSure Technologies, Inc., Bethlehem, PA) consisted of a 4 mm × 
20 mm nitrocellulose strip (SRHF04000, Millipore, Billerica, MA) with a 4 mm × 10 mm sample loading 
pad (glass-fiber No. 33, Schleicher & Schuell) at the upstream end and a 4 mm × 20 mm absorbent, waste 
pad (paper No. 470, Schleicher & Schuell) at the downstream end. The LF strip contained a test line of 
avidin-D and a control line of goat anti-mouse IgG antibodies (supporting information, Fig. S1). During the 
lateral flow assay, the digoxigenin and biotin-labeled DNA were immobilized at the test line by avidin-biotin 
binding. The up-converting phosphor (UCP) mouse anti-Dig conjugates were then captured by the 
immobilized DNA through the Dig anti-Dig interaction. The UCP particles not captured at the test line were 
immobilized at the control line by the interactions of the goat anti-mouse antibodies and the mouse anti-dig 
antibody-UCP conjugate. The detection was effectuated by exciting the “up-converting” phosphor (UCP) 
particles at infrared (IR) (~ 980 nm) wavelength and detecting emission in the visible spectrum (450 nm) 
[49]. As our analyzer is not yet equipped with a reader, a UCP Reader (UPlinkTM, OraSure Technologies, Inc., 
Bethlehem, PA) was used to read the DNA strips. 
 
3. Results and discussion 
3.1 Pouch volumes and mass loss 
The pouches were designed to store liquid reagents as well as to facilitate the pumping of the stored 
liquids. The pouch volumes, ranging from ~8 µl to 210 µl, were dictated by the assay requirements plus the 
dead volume (typically, about 5% of the pouch’s volume). The pouch wells were formed by drilling into a 
polycarbonate body with a 0.375’’ ball end mill. The pouch volume was controlled by the milling depth (Fig. 
S2 in supporting information depicts the pouch’s volume as a function of the cavity’s depth).  The volumes 
of nominally similarly sized pouches varied by less than 5%. 
To store liquids for extended periods of time, the pouch membrane must have low permeability to the 
vapors of the stored liquids. To enable long term storage, we envision replacing the polycarbonate membrane 
currently used with an aluminum foil barrier film (Tolas, Inc., Feasterville, PA). We tested the shelf life of 
liquid-filled pouches made with the aluminum foil by monitoring liquid mass loss from the pouches over a 
period of a few months. The ports in the bottom part of the pouch cavity were sealed with aluminum sealing 
tape after filling the pouch chamber with the reagent. We monitored two different liquids: DI water and pure 
ethanol (Ethyl Alcohol 200 Proof -Pharmco-AAPER) under room conditions. The masses of the liquid-filled 
pouches were monitored with an analytical balance (Ohaus Corp., Pine Brook, NJ). Fig. 6 depicts the relative 
average (n=3) mass losses of the water and ethanol pouches as functions of time. Over a period of one year, 
about 3% and 11% of the water and ethanol masses were, respectively, lost. Since in the nucleic acid 
cassettes the ethanol is not pure, but blended with other ingredients to a concentration smaller than 60%, it is 
anticipated that the actual lose of ethanol from the pouch will be significantly smaller than 11%. In 
conclusion, it appears that the pouches can reasonably store buffers for a period of one year under ambient 
conditions (~20-22˚C) with minimum mass loss.  
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Fig. 6: The mass loss (%) of pouch-stored liquids water (upright triangles) and ethanol (squares), as 
functions of time under room conditions. 
 
3.2 On-chip Thermal Cycling 
To achieve fast thermal cycling, a slender, 400μm high reaction chamber sandwiched between two 
120μm thick polycarbonate films was fabricated. To reduce heat losses, the reaction chamber was surrounded 
with air-filled grooves (Fig 1A and Fig. 2) that serve to insulate the reactor. A thermoelectric (TE) unit (Laird 
Technologies, Inc., St. Louis, Missouri, USA) was positioned beneath the PCR chamber and another, similar 
unit above the chamber (Fig. 1B2). A K-type thermocouple was attached to the top TE unit at the interface 
between the cassette and the TE unit to provide input to the feedback temperature controller. Digital control was 
executed with a custom-written, nonlinear, proportional–integral–derivative (PID) control algorithm. To 
reduce the thermal contact resistance between the thermoelectric units and the PCR chamber, normal force 
was applied to press the thermoelectric units against the PCR chamber. The system was calibrated and tested 
with a calibration cassette with thermocouples embedded inside the liquid-filled reaction chamber. The actual, 
disposable cassette that was used for the assays did not contain any thermocouples. 
To illustrate the performance of the thermal controller, Figure 7a depicts the calibration reactor’s 
temperature as a function of time. The thermocouple was inserted mid-length, mid-width, next the inner, top 
surface of the chamber. Fig.7b provides an amplified segment of the temperature trace over one thermal 
cycle. Fig. 7b depicts the set temperature (solid line), the temperature at the top outer surface (dashed line), 
the temperature at the bottom outer surface (dashed-dot line), and the temperature inside the reactor (red line) 
as functions of time. The heating time from room temperature to 94˚C was ~13 s at a heating rate of ~5.2˚C 
/s. The cooling rate from 95˚C to 60˚C was ~6˚C /s. The corresponding heating rate of typical benchtop 
thermal cyclers ranges from ~1˚C /s to 3˚C /s. The total temperature ramp time of one complete cycle of 
denaturing, annealing, and extension was about 25 s (without counting the dwelling time of 5 s – 15 s at each 
temperature). The maximum temperature difference between the bottom and the top outer surfaces of the 
chip was less than 0.5˚C.  The chamber’s inner temperature tracked the set temperature with a time delay 
smaller than 5 s. 
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Fig.  7: (a) The PCR chamber’s temperature as a function of time. (b) An enlarged segment of (a) spanning 
the time interval from 80s to 200s (b) and depicting, respectively, the temperatures at the outer bottom 
surface in contact with the TE unit (dotted line) and the top outer surface in contact with the TE unit 
(dashed-dot line), inside the reactor (solid red line), and the set temperature (solid line) as functions of time. 
 
 
3.3 On-Chip Dry Storage of (RT-)PCR Reagents 
Dry PCR mix (Taq polymerase, primers, dNTPs, buffer salts) or RT-PCR mix (reverse transcriptase, Taq 
polymerase, primers, dNTPs, buffer salts), encapsulated with paraffin, was pre-stored in the PCR reaction 
chamber in dry form. The (RT-)PCR mix can be either first encapsulated with protective paraffin film outside 
the reactor and then inserted into the chamber or dried and encapsulated with paraffin in-situ during the 
reaction chamber’s assembly [20, 42]. Fig. 8a and 8b show, respectively a photograph and a schematics of 
the reaction chamber with the pre-stored reagents. Once the nucleic acids were eluted from the upstream 
isolation membrane and introduced into the reaction chamber, the inlet and exit valves closed. The chamber 
was then heated, the paraffin melted and moved out of the way by the action of surface tension forces and 
buoyancy, and the (RT-)PCR mix was hydrated and reconstituted [20]. The method of pre-storing the PCR 
reagents greatly simplifies the flow control as well as offers a strategy for prolonged storage of chips without 
a need for refrigeration.  
The performance of the PCR reactor with the dry stored reagents was tested by amplifying target 
analytes at various concentrations.  In the PCR tests, we successfully amplified DNA targets at 
concentrations as low as ~200 copies. Fig. 8c depicts a representative electropherogram of an agarose gel 
electrophoresis resulting from ~1.5 ng B Cereus DNA target, showing the appropriate 305 bp amplicon 
product. Lanes 1 and 2 correspond, respectively, to the products of the on-chip PCR reactor with wet 
reagents and the on-chip PCR reactor with wax-encapsulated, dry reagents.  The band in Lane 2 is slightly 
weaker than that in Lane 1. We suspect that the lower efficiency of the reaction with the encapsulated 
reagents resulted from our relatively primitive drying procedure. The reagents were dried at room 
temperature in moderate vacuum.  The drying process may adversely affected enzyme activity.  It is likely 
that more sophisticated drying techniques such as freeze-drying would better preserve enzymes’ integrity and 
would lead to better PCR efficiency.  Preliminary testing of the shelf life of the pre-loaded, dried reagents 
showed successful amplification of target nucleic acids with reagents stored at room conditions for up to five 
months [20]. 
Fig. 8d features a representative electropherogram of RT-PCR with armored RNA using on-chip, 
preloaded, dry reagents. The RNA was isolated from a 100μl armored RNA sample of 1×105 virions/ml. 
Lanes 1 and 2 correspond, respectively, to the amplicons (155 bp) of the on-chip PCR reactor with wet 
reagents and the on-chip PCR reactor with wax-encapsulated dry reagents. Witness the presence of a second 
(a) (b)
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band consisting of smaller molecules. We suspect that this second band resulted from primer-dimer 
formation during the RT-PCR reaction, probably due to the use of single step RT and PCR reactions, the 
relatively high concentration of primers, and un-optimized reaction conditions.  
To verify that the paraffin itself does not adversely affect the amplification process, we deposited a 
paraffin layer in the PCR chamber in the same way as we would deposit paraffin for the reagents' storage, but 
without any reagents. Instead, the reagents were supplied in liquid form. The PCR products from the reactor 
with the paraffin patch and the PCR reactor without the paraffin patch yielded nearly identical gel 
electrophoresis bands (not shown). Not surprisingly, the paraffin itself has no adverse effect on the 
amplification process.  
Paraffin-passivated dried
PCR reagents
Valve
Thermal
guards
 (a) 
Valve
PCR
Chamber
Dried
Reagents Paraffin
(b) 
1               2
Marker
VIII
305bp
 (c) 
155bp
1            2          3
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VIII (d) 
Fig. 8: (a) A photograph of the modular PCR chamber with the paraffin-encapsulated, pre-loaded, dry 
reagents. (b) Cross-section of a reactor with the paraffin-encapsulated, pre-loaded, dry reagents. (c) Agarose 
gel (1.5%) electropherograms of PCR products (305 bp) amplified from ~1.5 ng B.Cereus DNA (30 cycles). 
Lanes 1 and 2 correspond, respectively, to the products of the PCR reactor with liquid reagents and the PCR 
reactor with wax-encapsulated dry reagents. (d) Agarose gel (2%) electropherograms of RT-PCR products 
(155bp) amplified from armored RNA isolated from a 100-μl sample of 1×105 virions/ml (35 cycles). Lanes 
1, 2 and 3 correspond, respectively, to the products of the RT-PCR reactor with liquid reagents, the reactor 
with dry reagents, and the negative control (no target) with dry reagents. 
 
3.4 On-chip Nucleic Acid Extraction 
The purity of the nucleic acid template and the presence of inhibitors critically affect the sensitivity, 
reliability, and specificity of the RT-PCR/PCR reactions. Hence, the module for nucleic acids isolation, 
purification, and concentration plays a critical role in the successful operation of the integrated cassette. Here, 
we utilized solid-phase extraction based on the chaotrope-silica method [1, 32, 43, 45]. A 2 mm diameter disc 
of silica fiber matrix was snugly fitted in a chamber (Fig. 9a). The silica disc facilitated easier assembly than 
the use of a packed bead column [45]. 
When valve V2 was open and valve V3 closed (Fig. 1A), the sample was pre-mixed with chaotropic salt 
and pumped through the porous silica membrane (Fig. 9a), and then the membrane was washed with 
ethanol-based buffers. Next, the membrane was dried with heated air-flow at a vacuum pressure of 600 mbar 
to remove the residual buffers retained in the membrane. Valve V2 was then closed, valve V3 opened, and 
the nucleic acids were eluted into the PCR chamber by pumping pure water (elution buffer) through the 
membrane. Only a fraction of the eluted template was transferred into the 20 µl (RT-)PCR chamber located 
downstream of the isolation chamber.  
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Fig. 9: (a) Schematic depiction of the silica membrane isolation chamber. (b) The DNA concentration 
C(n) of consecutive eluted aliquots (n) from the on-chip silica membrane; the error bar represents the scatter 
of data from three independent measurements. (c) Real-time PCR of samples taken from the consecutive 
aliquots: the fluorescent intensity (arbitrary units) is depicted as a function of time. 
 
 
Literature and experience showed that the presence of inhibitors, especially ethanol, has an adverse 
effect on amplification’s efficiency. To better understand the elution process, we examined the nucleic acid 
concentration of successive aliquots eluted from the isolation chamber.  To obtain the nucleic acids, we 
mixed 100 μl of B. Cereus culture (~2.85×107 cells/ml corresponding to ~16.6 ng of B. Cereus genomic 
DNA [50] in the sample) with 100 μl lysis buffer (QIAGEN Inc., Valencia, CA 91335) at 59˚C for 30 min, 
passed the lysate through the isolation chamber, and washed the membrane using the standard procedure 
described in section 2. Six successive aliquots, 10 μl each, were eluted from the membrane with water. We 
labeled the aliquots according to their position in the elution sequence, i.e, 1, 2, and 3 stands, respectively, 
for the first, second, and third eluted aliquot. The DNA concentration of each aliquot was measured with a 
fluorimeter (Turner Biosystem TBS-380, Sunnyvale, CA). The fluoremetric measurement was carried out on 
portions taken from 15-20 fold diluted aliquots mixed with PicoGreenTM dye (Molecular Probes, Inc., 
Eugene, OR) that selectively binds to double-stranded DNA. Fig. 9b depicts the nucleic acid concentration 
of each aliquot as a function of its position in the elution series. The figure represents the average of three 
experiments, and the error bars correspond to one standard deviation. The first few aliquots contained most 
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of the eluted nucleic acids and the concentration of nucleic acids in the aliquots decreased nearly 
exponentially as a function of the aliquot number. The nucleic acid concentration could be correlated with a 
function of the form ( ) nenC 24.0522 −= , where C is the concentration (ng/mL) and n is the aliquot number.  
Next, 5μl of each of the aliquots of the eluted whole B. Cereus genomic DNA was further diluted with 
water and mixed with PCR reagents (see section 2.6) and SYTO® 9 fluorescent dye (10 μM, Molecular 
Probes / Invitrogen UNY1001, 5 mM in DMSO) to form a 25-μl reaction volume, which was then amplified 
in a real-time PCR machine (Chromo4, Bio-Rad Laboratories, Hercules, CA 94547). Fig. 9c depicts the 
fluorescence intensity of the PCR products corresponding to the various aliquots as a function of time. A no 
template control was also run to ensure that the reagents were free of contamination (no false positives). 
Consistent with the fluorometric DNA concentration measurement (Fig. 10b), the time elapsing until the 
appearance of a detectable signal increased as the aliquot number increased (and the corresponding DNA 
concentration decreased), thus reaffirming that the DNA concentration in the aliquots decreased as the 
aliquot number increased. Fig. 9c suggest that the wash and drying steps used were sufficiently effective to 
suppress inhibitory effects that can be caused by residual ethanol in the elute [43]. 
 
 
3.5 Detection of Pathogenic Bacteria  
To demonstrate the ability of our microfluidic cassette to detect bacteria in body fluids, we prepared 
samples consisting of 100μl saliva spiked with bacterial B. Cereus cells into concentration of 1.4×107 
cells/ml, 1.4×105 cells/ml, 1.4×104 cells/ml, and 0 cells/ml (negative control). Each sample was inserted into 
the sample (mixing) chamber, the cassette was activated, inserted into the analyzer, and processed. Since our 
analyzer does not yet include an optical reader, at the conclusion of the process, the completed lateral flow 
strip was scanned with an IR laser reader (Uplink, OraSure Technologies, Inc., Bethlehem, PA) to obtain the 
test results. The tests were repeated at least three times.  
Fig. 10a depicts a representative result of the lateral flow strip reading obtained from the test of 100-μl 
(1.4×104 cells/ml) B. Cereus saliva sample. The figure depicts the relative fluorescence (450 nm) intensity as 
a function of the position along the strip. The two peaks correspond to the test line and the control line. As 
the target analyte concentration increases, the test peak area increases and the control peak area decreases. 
For scans of lateral flow strips obtained with samples of other concentrations, see supplemental information 
Fig. S3. The results of the test are usually reported as the ratio (T/C) of the test (T) and control (C) peak areas. 
Fig. 10b depicts the ratio T/C as a function of the bacteria concentration. The T/C ratio decreased nearly 
exponentially as the bacteria concentration decreased.  The test is deemed to be positive when the ratio T/C 
exceeds a predetermined threshold value (e.g., 0.5). We estimate that the detection limit of our current device 
is ~ 103 to 104 cells/mL. 
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Fig. 10: (a) Scan of processed saliva-spiked with B. Cereus (1.4×104 cells/mL) sample. The emission 
intensity (in relative fluorescent units) is depicted as a function of position along the strip. (b) The ratio of the 
test and the control signals (T/C) of saliva samples spiked with B. Cereus as a function of cell concentration 
(cells/mL). 
3.6 Detection of Armored RNA HIV  
To demonstrate the ability of the system to detect viral particles, we carried out a sequence of 
experiments with armored RNA HIV samples (Asuragen, Inc., Austin, TX 78744). Samples were prepared 
by spiking 100μl of saliva with armored RNA virions into concentration of 106 virions/ml , 105 virions/ml, 
and 0 virions/ml (negative sample). The samples were processed in the microfluidic cassette according to the 
protocols described earlier in the paper. The PCR was run for 35 cycles and the results of the tests were 
analyzed with the lateral flow strip. The tests were repeated at least three times. The positive samples yielded 
a high test peak and a low control peak, while the negative sample yielded a low test peak and a high control 
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peak (See Fig. S4 in Supplemental Information). We suspect that the weak test peak present in the negative 
sample scan is due to the formation of primer-dimer in the RT-PCR product (see Fig. 8d). Since, in contrast 
to the electropherogram, the lateral flow assay cannot distinguish between the amplicons and the 
primer-dimers, the presence of primer dimers may adversely affect the detection sensitivity of the assay. 
Further optimization of the RT-PCR e.g. by application of a hot-start Taq polymerase is expected to reduce 
primer-dimer formation. The ratio (T/C) of the areas of the test (T) and the control (C) signals is depicted in 
Fig. 11. 
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Fig. 11: The ratio of test and control peaks as a function of armored RNA virion concentration 
3.7 Detection of HIV 
To prove the ability of the cassette to detect actual infectious diseases, we carried out a few preliminary tests 
with samples containing HIV I. Samples were prepared by spiking HIV in saliva at concentrations of 107 
virons/ml, 105 virions/ml, 103 virions/ml, and 0 virions/ml (negative control). For safety reasons, prior to 
their introduction into the cassette, the HIV samples were inactivated with 2 volumes of binding buffer 
(Roche Applied Science, Mannheim, Germany) in a biosafety laboratory. The inactivated samples were then 
inserted into the cassette, and the nucleic acids were isolated and eluted to produce about 25 μl of eluted 
RNA from each sample. A 5 μl portion of each elute was amplified in on-chip RT-PCR. The RT-PCR 
products were visualized by agarose gel electrophoresis or detected with the lateral flow assay. Only 1 μl of 
the PCR products was transmitted to the lateral flow strip. Fig. 12 depicts the ratio of test and control peaks of 
the HIV samples. Our preliminary results indicate that the cassette could detect down to 105 HIV virions/mL. 
The relatively high peak associated with the negative control is possibly caused by the formation of a 
primer-dimer.  This assessment is supported by the appearance of a secondary band in the 
electropherograms similar to the one depicted in Fig. 8d and could be due to the presence of forward and 
reverse primers during the reverse transcriptase step.  
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Fig. 12: The ratio of test and control peaks as a function of HIV concentration (n=1). 
 
4. Conclusions and Outlook 
An easy to use, automated, portable system for the detection of nucleic acids at the point of care is 
described. The system accepts an unprocessed sample of body liquid or other liquid, processes the sample, 
and provides an answer. The system performs multiple tasks including sample lysis; nucleic acid extraction, 
concentration, and purification; nucleic acid amplification; and detection. The system consists of a relatively 
inexpensive, disposable, single use cassette and a durable analyzer. There is no exchange of liquids between 
the analyzer and the cassette; thus minimizing the possibility of cross-contamination. 
The cassette integrates pouch-based liquid storage and pumping; diaphragm valves; reaction chambers 
for fluid pumping, lysis, solid-phase nucleic acid isolation and purification, thermal cycling; dry storage of 
(RT-)PCR reagents with “just-in-time” release; lateral flow-based detection; and waste storage. The cassette 
was manufactured with polycarbonate as well as other plastic films. In small quantities, the cassette was 
fabricated with a laser cutter and a CNC milling machine. In large quantities, it is anticipated that the cassette 
will be manufactured by injection molding techniques. 
The analyzer includes linear mechanical actuators to compress the cassette’s pouches in a controlled 
manner for liquid dispensing and to actuate the cassette’s valves to control the flow; thermoelectric units to 
control the temperature of the (RT-)PCR chamber, heaters to control the temperature of the nucleic acid 
isolation chamber and help remove volatile components; a vibrator to assist in mixing; a vacuum pump to 
assist in flow control and the removal of PCR inhibitors; and a microprocessor to time and control the 
sequence of operations.  The analyzer interacts with computer-based software through a graphical user 
interface (GUI). However, the analyzer still lacks integrated optics for signal detection.  
The performance of the various modules was evaluated independently and the performance of the entire 
cassette was tested with saliva samples spiked with bacteria (B. Cereus) to demonstrate DNA detection 
capability and samples laden with Armor RNA HIV virons to demonstrate RNA detection capability. A 
limited number of experiments were also carried out with saliva samples laden with HIV virus. The system, 
in its current state, successfully and reproducibly detected down to 1000 pathogen particles in the sample. It 
is anticipated that this generic system will be able to detect other pathogens with similar results by 
adjustment of the primers and reagents utilized. 
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